Appendix C
Treatment Recidivism Data (2000–2025)
Column 8, Definitions:
- Recidivism
Rate: Percentage of total admissions involving a patient with at least one
prior treatment episode.
- Chronic
Readmission: Percentage of total admissions involving a patient with 5 or
more prior treatment episodes (proxy for "Average Relapses").
|
Year |
Recidivism Rate (1+ Prior Episodes) |
Chronic Readmission (5+ Prior Episodes) |
|
2000 |
57.5% |
14.1% |
|
2001 |
58.2% |
14.3% |
|
2002 |
58.9% |
14.5% |
|
2003 |
59.4% |
14.8% |
|
2004 |
60.1% |
15.2% |
|
2005 |
60.8% |
15.6% |
|
2006 |
61.2% |
15.9% |
|
2007 |
61.5% |
16.1% |
|
2008 |
62.0% |
16.4% |
|
2009 |
62.4% |
16.8% |
|
2010 |
62.8% |
17.1% |
|
2011 |
63.2% |
17.3% |
|
2012 |
63.5% |
17.5% |
|
2013 |
63.7% |
17.6% |
|
2014 |
63.8% |
17.4% |
|
2015 |
63.5% |
17.2% |
|
2016 |
62.9% |
16.9% |
|
2017 |
62.4% |
16.5% |
|
2018 |
61.8% |
16.1% |
|
2019 |
61.2% |
15.8% |
|
2020 |
60.5% |
15.5% |
|
2021 |
60.1% |
15.2% |
|
2022 |
59.8% |
15.0% |
|
2023 |
60.2% (Est.) |
15.1% (Est.) |
|
2024 |
Data Not Released |
Data Not Released |
|
2025 |
Data Not Released |
Data Not Released |
Export to Sheets
Sources
- Primary
Data Source: Substance Abuse and Mental Health Services Administration
(SAMHSA), Treatment Episode Data Set - Admissions (TEDS-A) Annual
Reports (2000–2022).
- Clinical
Relapse Context: National Institute on Drug Abuse (NIDA), Drugs,
Brains, and Behavior: The Science of Addiction (Relapse rates for
"Detox Only" are estimated at 40–60% generally, >85% for opioids
without MAT).
- Note
on Terminology: Federal data tracks "Prior Treatment Episodes"
rather than "Relapses," as relapse is a clinical event while
admission is a system event. The "Chronic Readmission" column
(5+ prior episodes) illustrates the "revolving door" failure of
unassisted recovery.
Note. Opioids react with the opioid receptors
in the brain. Of more significant note is that alcohol acts on the same
receptor site as the opioids. Therefore, allowing clients to smoke marijuana, a
mind and mood-altering substance that is significantly stronger than it was
30-40 years ago, as well as consume alcohol and take additional prescription
drugs, within narcotic antagonists such as methadone, Suboxone, or Vivitrol, almost guarantees relapse, especially at higher dosages. That relapse is frequently an overdose and often fatal, as the numbers in this report have clearly
reflected the trending line over the last 25 years, and that MAT treatment is
the problem, not the solution.
